AU4598701A - Compositions and methods for gene therapy - Google Patents

Compositions and methods for gene therapy

Info

Publication number
AU4598701A
AU4598701A AU4598701A AU4598701A AU4598701A AU 4598701 A AU4598701 A AU 4598701A AU 4598701 A AU4598701 A AU 4598701A AU 4598701 A AU4598701 A AU 4598701A AU 4598701 A AU4598701 A AU 4598701A
Authority
AU
Australia
Prior art keywords
compositions
methods
gene therapy
therapy
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4598701A
Inventor
Jean-Marie Vogel
Egisto Boschetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biosphere Medical Inc
Original Assignee
Biosphere Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US19190200P priority Critical
Application filed by Biosphere Medical Inc filed Critical Biosphere Medical Inc
Priority to PCT/US2001/009618 priority patent/WO2001072280A2/en
Publication of AU4598701A publication Critical patent/AU4598701A/en
Application status is Pending legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1658Proteins, e.g. albumin, gelatin
AU4598701A 2000-03-24 2001-03-23 Compositions and methods for gene therapy Pending AU4598701A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US19190200P true 2000-03-24 2000-03-24
PCT/US2001/009618 WO2001072280A2 (en) 2000-03-24 2001-03-23 Microspheres for gene therapy

Publications (1)

Publication Number Publication Date
AU4598701A true AU4598701A (en) 2001-10-08

Family

ID=22707377

Family Applications (1)

Application Number Title Priority Date Filing Date
AU4598701A Pending AU4598701A (en) 2000-03-24 2001-03-23 Compositions and methods for gene therapy

Country Status (2)

Country Link
AU (1) AU4598701A (en)
WO (1) WO2001072280A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332160B2 (en) 2002-07-12 2008-02-19 Boston Scientific Scimed, Inc. Medical device and method for tissue removal and repair
CA2503949C (en) * 2002-10-29 2012-10-23 Toray Industries, Inc. Embolization material
FR2858628B1 (en) * 2003-08-04 2008-01-04 Polyplus Transfection New nucleic acid complex assets for arn interference and their use for the expression of proteins inhibiber
US8821859B2 (en) 2004-05-19 2014-09-02 Agency For Science, Technology And Research Methods and articles for the delivery of therapeutic agents
WO2006042161A2 (en) 2004-10-07 2006-04-20 E.I. Dupont De Nemours And Company Polysaccharide-based polymer tissue adhesive for medical use
EP1844772A1 (en) * 2006-04-06 2007-10-17 Polyplus-Transfection SA Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
US8282959B2 (en) 2006-11-27 2012-10-09 Actamax Surgical Materials, Llc Branched end reactants and polymeric hydrogel tissue adhesives therefrom
WO2009029443A2 (en) * 2007-08-24 2009-03-05 E. I. Du Pont De Nemours And Company Method for embolization using liquid embolic materials
EP2214731B1 (en) 2007-11-14 2014-05-14 Actamax Surgical Materials LLC Oxidized cationic polysaccharide-based polymer tissue adhesive for medical use
US8551136B2 (en) 2008-07-17 2013-10-08 Actamax Surgical Materials, Llc High swell, long-lived hydrogel sealant
WO2010017215A2 (en) * 2008-08-04 2010-02-11 The Regents Of The University Of California Biodegradable microspheres and methods of use thereof
US9044529B2 (en) 2008-11-19 2015-06-02 Actamax Surgical Materials, Llc Hydrogel tissue adhesive formed from aminated polysaccharide and aldehyde-functionalized multi-arm polyether
US8466327B2 (en) 2008-11-19 2013-06-18 Actamax Surgical Materials, Llc Aldehyde-functionalized polyethers and method of making same
EP2416811B1 (en) 2009-04-09 2015-09-09 Actamax Surgical Materials LLC Hydrogel tissue adhesive having reduced degradation time
US8580950B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US8580951B2 (en) 2009-07-02 2013-11-12 Actamax Surgical Materials, Llc Aldehyde-functionalized polysaccharides
US9758606B2 (en) 2012-07-31 2017-09-12 The Trustees Of Columbia University In The City Of New York Cyclopropenium polymers and methods for making the same
US8859705B2 (en) 2012-11-19 2014-10-14 Actamax Surgical Materials Llc Hydrogel tissue adhesive having decreased gelation time and decreased degradation time
WO2015017340A2 (en) 2013-07-29 2015-02-05 Actamax Surgical Materials, Llc Low swell tissue adhesive and sealant formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676927B1 (en) * 1991-05-29 1995-06-23 Ibf Microspheres used for vascular occlusions therapeutic injectable solutions containing them.
EP0797988B1 (en) * 1993-07-19 2009-01-14 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
AU700903B2 (en) * 1994-10-12 1999-01-14 Focal, Inc. Targeted delivery via biodegradable polymers
US6210707B1 (en) * 1996-11-12 2001-04-03 The Regents Of The University Of California Methods of forming protein-linked lipidic microparticles, and compositions thereof

Also Published As

Publication number Publication date
WO2001072280A3 (en) 2002-01-31
WO2001072280A2 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
EG23122A (en) Pyrrolcarboxamides and pyrrolcarbothioamides
AU2001276160B2 (en) Probiotic recolonisation therapy
HRP20020787A2 (en) Method of treatment using ligand-immunogen conjugates
PL351552A1 (en) Gypsum compositions and related methods
EP1463438A4 (en) Endomural therapy
AU3459301A (en) Compositions and methods for performing biological reactions
HK1073660A1 (en) Methods and compositions and rna interference
AU2002357119A1 (en) Mitocidal compositions and methods
IL160933D0 (en) Methods and compositions for treating ?cap associated diseases
SI1317479T1 (en) Methods and compositions for diseases associated with amyloidosis
AU4570901A (en) Biocidal methods and compositions
AU4562801A (en) Immunomodulatory formulations and methods for use thereof
AU2625501A (en) Compositions and methods for gene silencing
GB0003397D0 (en) Therapeutic agents
GB0012671D0 (en) Therapeutic agents
AU2002229075A1 (en) Agents and methods for treating pain
AU7159501A (en) Methods and compositions for transcription-based nucleic acid amplification
GB0004003D0 (en) Therapeutic agents
DE60113683D1 (en) Radiotherapy
EP1274861A4 (en) Compositions and methods for identifying and targeting cancer cells
ZA200209638B (en) Compositions and methods for the treatment of cancer.
AU4543701A (en) Lightweight methods and compositions for well treating
EP1408986A4 (en) Proteomimetic compounds and methods
GB0018473D0 (en) Therapeutic agents
EP1223932A4 (en) Compounds and methods